FDA approves another Darzalex combination treatment
Genmab has received the green light from the US agency for its drug Darzalex in combination with Carfilzomib and Dexamethasone.
by marketwire, translated by catherine brett
The US Food and Drug Administration (FDA) has approved another combination treatment involving Darzalex.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Genmab pipeline hype makes investment bank uneasy
For subscribers
Anthony Mancini will help Genmab take its next steps
For subscribers
